# Arq, Inc.: overview ARQ · Nasdaq · CIK 1515156 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/arq.md) · [Financials](/companies/arq/financials.md) · [Filings](/companies/arq/filings.md) · [Insiders](/companies/arq/insiders.md) Latest reported revenue: [$29.9m](/filings/0001515156-26-000114.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001515156-26-000114). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [34.8](/filings/0001515156-25-000138.md) | [27.0 d](/filings/0001515156-26-000021.md) | [27.2](/filings/0001515156-26-000062.md) | [28.6](/filings/0001515156-26-000114.md) | [35.1](/filings/0001515156-25-000138.md) | [29.4 d](/filings/0001515156-26-000021.md) | [29.1](/filings/0001515156-26-000062.md) | [29.9](/filings/0001515156-26-000114.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [5.8%](/filings/0001515156-25-000138.md) | [1.5% d](/filings/0001515156-26-000021.md) | [2.4%](/filings/0001515156-26-000062.md) | [(6.3%)](/filings/0001515156-26-000114.md) | [(2.4%)](/filings/0001515156-25-000138.md) | [(174.1%) d](/filings/0001515156-26-000021.md) | [(3.4%)](/filings/0001515156-26-000062.md) | [(0.2%)](/filings/0001515156-26-000114.md) | | Net margin | % | [4.7%](/filings/0001515156-25-000138.md) | [(5.0%) d](/filings/0001515156-26-000021.md) | [(0.1%)](/filings/0001515156-26-000114.md) | [(8.3%)](/filings/0001515156-26-000114.md) | [(1.9%)](/filings/0001515156-25-000138.md) | [(170.0%) d](/filings/0001515156-26-000021.md) | [(3.9%)](/filings/0001515156-26-000114.md) | [(2.5%)](/filings/0001515156-26-000114.md) | | Diluted EPS | $ per share | [0.04](/filings/0001515156-25-000138.md) | not reported | [0.00](/filings/0001515156-26-000062.md) | [(0.06)](/filings/0001515156-26-000114.md) | [(0.02)](/filings/0001515156-25-000138.md) | not reported | [(0.02)](/filings/0001515156-26-000062.md) | [(0.02)](/filings/0001515156-26-000114.md) | | Free cash flow | $m | [(5.8) d](/filings/0001515156-25-000138.md) | [(37.8) d](/filings/0001515156-26-000021.md) | [(9.5)](/filings/0001515156-26-000062.md) | [(1.4) d](/filings/0001515156-26-000114.md) | [3.1 d](/filings/0001515156-25-000138.md) | [(3.5) d](/filings/0001515156-26-000021.md) | [(0.7)](/filings/0001515156-26-000062.md) | [(4.0) d](/filings/0001515156-26-000114.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [100](/filings/0001515156-22-000005.md) | [103](/filings/0001515156-24-000036.md) | [99.2](/filings/0001515156-25-000014.md) | [109](/filings/0001515156-26-000021.md) | [120](/filings/0001515156-26-000021.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [4.8%](/filings/0001515156-23-000024.md) | [(11.7%)](/filings/0001515156-24-000036.md) | [(13.4%)](/filings/0001515156-25-000014.md) | [(1.8%)](/filings/0001515156-26-000021.md) | [(44.0%)](/filings/0001515156-26-000021.md) | | Net margin | % | [60.2%](/filings/0001515156-23-000024.md) | [(8.7%)](/filings/0001515156-24-000036.md) | [(12.3%)](/filings/0001515156-25-000014.md) | [(4.7%)](/filings/0001515156-26-000021.md) | [(43.7%)](/filings/0001515156-26-000021.md) | | Diluted EPS | $ per share | [3.27](/filings/0001515156-23-000024.md) | [(0.48)](/filings/0001515156-24-000036.md) | [(0.42)](/filings/0001515156-25-000014.md) | [(0.14)](/filings/0001515156-26-000021.md) | [(1.27)](/filings/0001515156-26-000021.md) | | Free cash flow | $m | [19.8](/filings/0001515156-23-000024.md) | [(15.0)](/filings/0001515156-24-000036.md) | [(44.2)](/filings/0001515156-25-000014.md) | [(74.7)](/filings/0001515156-26-000021.md) | [(11.3)](/filings/0001515156-26-000021.md) | - Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/arq/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $4.8m | 1,862,764 | | Added +114,320 | | [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $4.6m | 1,814,114 | | Added +728,404 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.7m | 1,464,532 | | Added +33,082 | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $2.2m | 880,201 | | Added +70,496 | | [Peapod Lane Capital LLC](/funds/2050979.md) | 2026-06-30 | $2.0m | 787,880 | | Added +12,531 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $1.5m | 607,420 | | Reduced −154,770 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.5m | 598,059 | | Added +187,489 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $1.3m | 509,225 | | Added +319,335 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.3m | 508,965 | | Reduced −1,588,557 | | [DCF Advisers, LLC](/funds/1802493.md) | 2026-06-30 | $1.2m | 461,585 | | Added +133,782 | ## Recent filings [All 811 filings](/companies/arq/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-28 | 16:31 ET | [8-K](/filings/0001515156-26-000121.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001515156-26-000121 | | 2026-08-10 | 16:53 ET | [8-K](/filings/0001515156-26-000116.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001515156-26-000116 | | 2026-08-10 | 16:44 ET | [10-Q](/filings/0001515156-26-000114.md) | Quarterly report, period 2026-06-30 | 0001515156-26-000114 | | 2026-07-23 | 17:09 ET | [8-K](/filings/0001515156-26-000097.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001515156-26-000097 | | 2026-07-02 | 16:33 ET | [8-K](/filings/0001515156-26-000085.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001515156-26-000085 | | 2026-06-18 | 16:31 ET | [8-K](/filings/0001515156-26-000075.md) | 5.02 Departure or appointment of officers or directors | 0001515156-26-000075 | | 2026-06-11 | 16:31 ET | [8-K](/filings/0001515156-26-000073.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001515156-26-000073 | | 2026-05-27 | 16:32 ET | [8-K](/filings/0001515156-26-000069.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001515156-26-000069 | | 2026-05-06 | 16:33 ET | [8-K](/filings/0001515156-26-000064.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001515156-26-000064 | | 2026-05-06 | 16:30 ET | [10-Q](/filings/0001515156-26-000062.md) | Quarterly report, period 2026-03-31 | 0001515156-26-000062 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001515156-26-000021.md), filed Mar 10, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/501b10f3-cb4d-46c0-8b50-40b94410f77b) ## About the filer - CIK: 1515156 - Tickers: ARQ - Exchange: Nasdaq - SIC code: 2890 Miscellaneous Chemical Products - State of incorporation: not reported - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.